Further thoughts about the ILLUMINATE studies of tabalumab in SLE

Comment

David Isenberg. Ann Rheum Dis. 2016 Feb.

. 2016 Feb;75(2):e11.

doi: 10.1136/annrheumdis-2015-208709. Epub 2015 Nov 3.

No abstract available

Keywords: Corticosteroids; Systemic Lupus Erythematosus; Treatment.

Comment on

Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study.
Isenberg DA, Petri M, Kalunian K, Tanaka Y, Urowitz MB, Hoffman RW, Morgan-Cox M, Iikuni N, Silk M, Wallace DJ. Isenberg DA, et al. Ann Rheum Dis. 2016 Feb;75(2):323-31. doi: 10.1136/annrheumdis-2015-207653. Epub 2015 Sep 3. Ann Rheum Dis. 2016. PMID: 26338095 Clinical Trial.
From BLISS to ILLUMINATE studies: "Blys repetita placent"?
Chiche L, Jourde-Chiche N, Retornaz F, Cornec D. Chiche L, et al. Ann Rheum Dis. 2016 Feb;75(2):e10. doi: 10.1136/annrheumdis-2015-208702. Epub 2015 Oct 20. Ann Rheum Dis. 2016. PMID: 26487652 No abstract available.